Note Figure 1 of

Noah Lechtzin, MD MHS

Respiratory Effects of Amyotrophic Lateral Sclerosis: Problems and Solutions

http://www.aamr.org.ar/secciones/kin...tos_respir.pdf

shows about five to ten data points per patient in Figure 1, but dEMG technology is the most promising method of today:

Onders, et alia's Figure 1 of:

Identification of unexpected respiratory abnormalities in patients with amyotrophic lateral sclerosis through electromyographic analysis using intramuscular electrodes implanted for therapeutic diaphragmatic pacing

http://www.americanjournalofsurgery....598-4/fulltext

promises megabytes . . . and may well produce medical science basis as good as or maybe even better than biomarkers.